Advertisement

Cancer rehabilitation indicators for Europe

Published:December 12, 2012DOI:https://doi.org/10.1016/j.ejca.2012.10.028

      Abstract

      Little is known of cancer rehabilitation needs in Europe. EUROCHIP-3 organised a group of experts to propose a list of population-based indicators used for describing cancer rehabilitation across Europe. The aim of this study is to present and discuss these indicators. A EUROCHIP-3 expert panel reached agreement on two types of indicators. (a) Cancer prevalence indicators. These were proposed as a means of characterising the burden of cancer rehabilitation needs by time from diagnosis and patient health status. These indicators can be estimated from cancer registry data or by collecting data on follow-up and treatments for samples of cases archived in cancer registries. (b) Indicators of rehabilitation success. These include: return to work, quality of life, and satisfaction of specific rehabilitation needs. Studies can be performed to estimate these indicators in individual countries, but to obtain comparable data across European countries it will be necessary to administer a questionnaire to randomly selected samples of patients from population-based cancer registry databases. However, three factors complicate questionnaire studies: patients may not be aware that they have cancer; incomplete participation in surveys could lead to bias; and national confidentiality laws in some cases prohibit cancer registries from approaching patients. Although these studies are expensive and difficult to perform, but as the number of cancer survivors increases, it is important to document their needs in order to provide information on cancer control.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Verdecchia A.
        • Guzzinati S.
        • Francisci S.
        • et al.
        Survival trends in European cancer patients diagnosed from 1988 to 1999.
        Eur J Cancer. 2009; 45: 1042-1066
        • Gatta G.
        • van der Zwan J.M.
        • Casali P.G.
        • et al.
        Rare cancers are not so rare: the rare cancer burden in Europe.
        Eur J Cancer. 2011; 47: 2493-2511
        • De Angelis R.
        • Grande E.
        • Inghelmann R.
        • et al.
        Cancer prevalence estimates in Italy from 1970 to 2010.
        Tumori. 2007; 93: 392-397
        • Francisci S.
        • Capocaccia R.
        • Grande E.
        • et al.
        The cure of cancer: a European perspective.
        Eur J Cancer. 2009; 45: 1067-1079
      1. Grassi L, Travado L. The role of psychosocial oncology in cancer care. In: Coleman MP, Alexe DM, Albreht T, McKee M, editors. Responding to the challenge of cancer in Europe. Ljubliana: Institute of Public Health of the Republic of Slovenia; 2008. p.209-30. Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/97823/E91137.pdf (accessed on February 2012).

      2. Council of the European Union. Council conclusions on reducing the burden of cancer: 2876th Council meeting, Luxembourg, 10 June, 2008. Available from: http://www.eu2008.si/en/News_and_Documents/Council_Conclusions/June/0609_EPSCO-cancer.pdf (accessed on May 2012).

      3. EUROCHIP. Available from: www.tumori.net/eurochip (accessed on February 2012).

      4. World Health Organization. Health topics. Rehabilitation. Available from: http://www.who.int/topics/rehabilitation/en/ (accessed on October 2012).

      5. EUROCHIP-3 WP-6. Available from: http://www.tumori.net/eurochip/wp.php?page=6 (accessed on October 2012).

      6. EUROCHIP-3 WP-6 final report to the European Commission. Available from: http://www.tumori.net/eurochip/material/WP6/WP6_report.pdf (accessed on October 2012).

      7. PubMed. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ (accessed on February 2012).

        • Capocaccia R.
        • De Angelis R.
        Estimating the completeness of prevalence based on cancer registry data.
        Stat Med. 1997; 16: 425-440
        • De Angelis R.
        • Grande E.
        • Inghelmann R.
        • et al.
        Cancer prevalence estimates in Italy from 1970 to 2010.
        Tumori. 2007; 93: 392-397
        • Micheli A.
        • Mugno E.
        • Krogh V.
        • et al.
        Cancer prevalence in European registry areas.
        Ann Oncol. 2002; 13: 840-865
        • Maher J.
        • McConnell H.
        New pathways of care for cancer survivors: adding the numbers.
        Br J Cancer. 2011; 105: S5-S10
      8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr (accessed on February 2012).

      9. Baili P, Vicentini M, Tumino R, et al. A method for differentiating cancer prevalence according to health status, exemplified using a population-based sample of Italian colorectal cancer cases. Acta Oncol in press.

        • Maddams J.
        • Utley M.
        • Møller H.
        Levels of acute health service use among cancer survivors in the United Kingdom.
        Eur J Cancer. 2011; 47: 2211-2220
        • Mariotto A.
        • Warren J.L.
        • Knopf K.B.
        • Feuer E.J.
        The prevalence of patients with colorectal carcinoma under care in the US.
        Cancer. 2003; 98: 1253-1261
        • Gatta G.
        • Capocaccia R.
        • Berrino F.
        • Ruzza M.R.
        • EUROPREVAL Working Group
        Colon cancer prevalence and estimation of differing care needs of colon cancer patients.
        Ann Oncol. 2004; 15: 1136-1142
        • Chauvenet M.
        • Lepage C.
        • Jooste V.
        • Cottet V.
        • Faivre J.
        • Bouvier A.M.
        Prevalence of patients with colorectal cancer requiring follow-up or active treatment.
        Eur J Cancer. 2009; 45: 1460-1465
        • de Boer A.G.
        • Taskila T.
        • Ojajärvi A.
        • van Dijk F.J.
        • Verbeek J.H.
        Cancer survivors and unemployment: a meta-analysis and meta-regression.
        JAMA. 2009; 301: 753-762
        • Roelen C.A.
        • Koopmans P.C.
        • Groothoff J.W.
        • van der Klink J.J.
        • Bültmann U.
        Return to work after cancer diagnosed in 2002, 2005 and 2008.
        J Occup Rehabil. 2011; 21: 335-341
        • Roelen C.A.
        • Koopmans P.C.
        • van Rhenen W.
        • Groothoff J.W.
        • van der Klink J.J.
        • Bültmann U.
        Trends in return to work of breast cancer survivors.
        Breast Cancer Res Treat. 2011; 128: 237-242
        • Roelen C.A.
        • Koopmans P.C.
        • Groothoff J.W.
        • van der Klink J.J.
        • Bültmann U.
        Sickness absence and full return to work after cancer: 2-year follow-up of register data for different cancer sites.
        Psychooncology. 2011; 20: 1001-1006
        • Roelen C.A.
        • Koopmans P.C.
        • de Graaf J.H.
        • Balak F.
        • Groothoff J.W.
        Sickness absence and return to work rates in women with breast cancer.
        Int Arch Occup Environ Health. 2009; 82: 543-546
        • Taskila-Abrandt T.
        • Martikainen R.
        • Virtanen S.V.
        • Pukkala E.
        • Hietanen P.
        • Lindbohm M.L.
        The impact of education and occupation on the employment status of cancer survivors.
        Eur J Cancer. 2004; 40: 2488-2493
        • Taskila-Abrandt T.
        • Pukkala E.
        • Martikainen R.
        • Karjalainen A.
        • Hietanen P.
        Employment status of Finnish cancer patients in 1997.
        Psychooncology. 2005; 14: 221-226
        • Syse A.
        • Tretli S.
        • Kravdal Ø.
        Cancer’s impact on employment and earnings-a population-based study from Norway.
        J Cancer Surviv. 2008; 2: 149-158
        • Carlsen K.
        • Oksbjerg Dalton S.
        • Diderichsen F.
        • Johansen C.
        Risk for unemployment of cancer survivors: a Danish cohort study.
        Eur J Cancer. 2008; 44: 1866-1874
        • Carlsen K.
        • Oksbjerg Dalton S.
        • Frederiksen K.
        • Diderichsen F.
        • Johansen C.
        Cancer and the risk for taking early retirement pension: a Danish cohort study.
        Scand J Public Health. 2008; 36: 117-125
        • Amir Z.
        • Moran T.
        • Walsh L.
        • Iddenden R.
        • Luker K.
        Return to paid work after cancer: a British experience.
        J Cancer Surviv. 2007; 1: 129-136
        • Sharp L.
        • Timmons A.
        Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland.
        J Cancer Surviv. 2011; 5: 382-394
        • Mols F.
        • Thong M.S.
        • Vreugdenhil G.
        • van de Poll-Franse L.V.
        Long-term cancer survivors experience work changes after diagnosis: results of a population-based study.
        Psychooncology. 2009; 18: 1252-1260
        • Aaronson N.K.
        • Ahmedzai S.
        • Bergman B.
        • et al.
        The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
        J Natl Cancer Inst. 1993; 85: 365-376
        • Ware J.E.
        • Sherbourne C.D.
        36-item shortform health survey (SF-36). I. Conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
        • Zigmond A.S.
        • Snaith R.P.
        The hospital anxiety and depression scale.
        Acta Psychiatr Scand. 1983; 67: 361-370
        • Bill-Axelson A.
        • Garmo H.
        • Nyberg U.
        • et al.
        Psychiatric treatment in men with prostate cancer–results from a nation-wide, population-based cohort study from PCBaSe Sweden.
        Eur J Cancer. 2011; 47: 2195-2201
        • Thorsen L.
        • Gjerset G.M.
        • Loge J.H.
        • et al.
        Cancer patients’ needs for rehabilitation services.
        Acta Oncol. 2011; 50: 212-222
      10. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, vol. IX. IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer; 2007. Available from: http://ci5.iarc.fr/CI5i-ix/ci5i-ix.htm (accessed on October 2012).

        • Dalton S.O.
        • Laursen T.M.
        • Ross L.
        • et al.
        Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003.
        J Clin Oncol. 2009; 27: 1440-1445
        • van de Poll-Franse L.V.
        • Horevoorts N.
        • van Eenbergen M.
        • et al.
        The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts.
        Eur J Cancer. 2011; 47: 2188-2194